Publication | Open Access

Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease

Insulin ResistanceMetabolic SyndromeObesityMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseMedicineLiver PhysiologyDiabetesPathologyHepatotoxicityLiver DiseaseFatty Liver DiseasePharmacologyHepatic CeramidesHealth Sciences